1. Home
  2. SCPH vs ANTA Comparison

SCPH vs ANTA Comparison

Compare SCPH & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • ANTA
  • Stock Information
  • Founded
  • SCPH 2013
  • ANTA 2022
  • Country
  • SCPH United States
  • ANTA Singapore
  • Employees
  • SCPH N/A
  • ANTA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • ANTA Investment Bankers/Brokers/Service
  • Sector
  • SCPH Health Care
  • ANTA Finance
  • Exchange
  • SCPH Nasdaq
  • ANTA Nasdaq
  • Market Cap
  • SCPH 299.0M
  • ANTA 284.1M
  • IPO Year
  • SCPH 2017
  • ANTA 2025
  • Fundamental
  • Price
  • SCPH $5.67
  • ANTA $12.53
  • Analyst Decision
  • SCPH Buy
  • ANTA Strong Buy
  • Analyst Count
  • SCPH 3
  • ANTA 2
  • Target Price
  • SCPH $12.00
  • ANTA $19.25
  • AVG Volume (30 Days)
  • SCPH 2.0M
  • ANTA 21.0K
  • Earning Date
  • SCPH 11-12-2025
  • ANTA 08-12-2025
  • Dividend Yield
  • SCPH N/A
  • ANTA N/A
  • EPS Growth
  • SCPH N/A
  • ANTA N/A
  • EPS
  • SCPH N/A
  • ANTA 0.24
  • Revenue
  • SCPH $49,969,000.00
  • ANTA $56,997,910.00
  • Revenue This Year
  • SCPH $104.30
  • ANTA $65.94
  • Revenue Next Year
  • SCPH $76.06
  • ANTA $59.39
  • P/E Ratio
  • SCPH N/A
  • ANTA $51.18
  • Revenue Growth
  • SCPH 107.79
  • ANTA 405.62
  • 52 Week Low
  • SCPH $1.94
  • ANTA $10.19
  • 52 Week High
  • SCPH $6.28
  • ANTA $27.72
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.40
  • ANTA N/A
  • Support Level
  • SCPH $5.64
  • ANTA N/A
  • Resistance Level
  • SCPH $5.65
  • ANTA N/A
  • Average True Range (ATR)
  • SCPH 0.03
  • ANTA 0.00
  • MACD
  • SCPH -0.02
  • ANTA 0.00
  • Stochastic Oscillator
  • SCPH 66.67
  • ANTA 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

Share on Social Networks: